In addition, the rate of CD4 cell count decline was not significantly associated with progression to AIDS or death among 1731 HIV-positive, symptom-free patients with CD4 cell counts above 350 cells/μl who were studied before cART was developed. The gene discussed is CD4; the disease is AIDS.